#regulatory immunity

Duty free shops cannot claim automatic exemption from regulatory laws merely operating beyond the customs barrier, Bombay High Court held. It affirmed that drugs and cosmetics remain under regulatory control despite customs barrier fiscal exemptions.

CCI found no prima facie violation of the Competition Act in the complaint that the mandatory shift to FIPS-140-3 favoured a single token vendor, dismissing the alleged abuse of dominance claim. The ruling clears the way for MeitY's migration mandate, affecting the Controller of Certifying Authorities, Precision Biometric and other token manufacturers.